Finance

Lists
LABS:TSE
Medipharm Labs Corp
CAD 0,070
0,00%
(0,00) 1D
5 Okt., 16:00:00 GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for LABS...
Open
CAD 0,07
High
CAD 0,08
Low
CAD 0,07
Mkt. cap
29,90 m
Avg. vol.
110,35 k
Volume
78,10 k
52-wk high
CAD 0,10
52-wk low
CAD 0,06
EPS
-CAD 0,01
Beta
0,43
Shares outstanding
427,18 m
No. of employees
127
Open
CAD 0,07
High
CAD 0,08
Low
CAD 0,07
Mkt. cap
29,90 m
Avg. vol.
110,35 k
Volume
78,10 k
52-wk high
CAD 0,10
52-wk low
CAD 0,06
EPS
-CAD 0,01
Beta
0,43
Shares outstanding
427,18 m
No. of employees
127
News stories
From web sources and news partners
About Medipharm Labs Corp
CEO-
Employees127
Founded2015
HeadquartersBarrie, Ontario, Kanada
SectorPharmaceutical industry
Last report
13 Aug. 2026
Fiscal period
Q2 2026
EPS / Est. (CAD)
- / -
Revenue / Est. (CAD)
9,98 m / 8,93 m
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
11,45 m
11,06 m
8,96 m
9,98 m
Cost of goods sold
8,90 m
7,26 m
5,65 m
5,56 m
Cost of revenue
8,90 m
7,26 m
5,65 m
5,56 m
Research and development expenses
47,00 k
52,00 k
24,00 k
83,00 k
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4,50 m
4,40 m
4,28 m
3,93 m
Operating expense
4,74 m
4,77 m
4,30 m
4,35 m
Total operating expenses
13,64 m
12,03 m
9,96 m
9,90 m
Operating income
-2,19 m
-967,00 k
-994,00 k
82,00 k
Other non operating income
-
-
-
-
EBT including unusual items
-2,14 m
-1,97 m
-867,00 k
4,00 k
EBT excluding unusual items
-2,14 m
-965,00 k
-867,00 k
120,00 k
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
189,00 k
358,00 k
-2,00 k
-110,00 k
Net income
-2,14 m
-1,97 m
-867,00 k
4,00 k
Net profit margin
-18,71%
-17,79%
-9,67%
0,04%
Earnings per share
-
-
-
-
Interest and investment income
62,00 k
58,00 k
60,00 k
50,00 k
Interest expense
-16,00 k
-19,00 k
-15,00 k
-12,00 k
Net interest expenses
46,00 k
39,00 k
45,00 k
38,00 k
Depreciation and amortization charges
-
-
-
-
EBITDA
-1,78 m
-580,00 k
-621,00 k
458,00 k
Gain or loss from assets sale
181,00 k
-
-
-
AI content may include mistakes. Learn more
Google-programme